{
    "Trade/Device Name(s)": [
        "HemosIL Factor XII Deficient Plasma"
    ],
    "Submitter Information": "Instrumentation Laboratory Co.",
    "510(k) Number": "K180486",
    "Predicate Device Reference 510(k) Number(s)": [
        "K043459"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GJT"
    ],
    "Summary Letter Date": "March 22, 2018",
    "Summary Letter Received Date": "February 23, 2018",
    "Submission Date": "February 22, 2018",
    "Regulation Number(s)": [
        "21 CFR 864.7290"
    ],
    "Regulation Name(s)": [
        "Factor deficiency test"
    ],
    "Analyte Class(es)": [
        "coagulation",
        "hematology"
    ],
    "Analyte(s)": [
        "Factor XII Activity"
    ],
    "Specimen Type(s)": [
        "Citrated plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "IL Coagulation Systems",
        "ACL TOP Family",
        "ACL TOP Family 50 Series",
        "ACL TOP 300 CTS",
        "ACL TOP 500 CTS",
        "ACL TOP 700",
        "ACL TOP 700 CTS",
        "ACL TOP 700 LAS",
        "ACL TOP 350 CTS",
        "ACL TOP 550 CTS",
        "ACL TOP 750",
        "ACL TOP 750 CTS",
        "ACL TOP 750 LAS"
    ],
    "Method(s)/Technology(ies)": [
        "Activated partial thromboplastin time (APTT) assay",
        "Functional clotting assay"
    ],
    "Methodologies": [
        "Clotting time measurement",
        "Calibration curve interpolation"
    ],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for HemosIL Factor XII Deficient Plasma reagent for quantitative determination of factor XII activity in citrated plasma using APTT assay on IL Coagulation Systems.",
    "Indications for Use Summary": "Intended for in vitro diagnostic quantitative determination of factor XII activity in citrated plasma, based on activated partial thromboplastin time (APTT) assay, on IL Coagulation Systems.",
    "fda_folder": "Hematology"
}